K-Dense AI logo

K-Dense AI

AI AgentVerified85% conf

AI agent platform for scientific and biotech analysis that accelerates research cycles through multi-agent systems

k-dense.ai

📍 Palo Alto, CA

Verified Data

💰
Est. Revenue$500K-$2M ARR

Based on $12M Series A funding in 2025 and 6-person team, typical B2B SaaS metrics suggest $500K-$2M ARR. Freemium model with $50 free credits and thousands of users indicates early revenue generation.

🚀
Funding$12M Series A led by Accel
🔗healthtechdigital.com
👥
Usersthousands of users

The platform's open-source component is used by "thousands worldwide" and K-Dense Web is trusted by "thousands of professionals"

🧑‍💻
Team Size6 employees

The small core team includes **six listed individuals**

🏷️
StageSeries A (2025)
📅
Founded2025

Company Profile

ModelOpen-source + hosted platform
VerticalBiotech, Healthcare, Science, Finance, Engineering
ClientsMGH, Harvard Medical School (Professor David Sinclair)
BuyersScientists, researchers, engineers, and professionals across biotech, healthcare, finance, and engineering fields
PricingFreemium with $50 free credits, no credit card required

Contact

Strategic Analysis

Strategy

Dual-track approach combining open-source Claude Scientific Skills (170+ skills) to drive adoption with premium K-Dense Web platform (200+ skills, 60 exclusive) for monetization. Targeting scientific and biotech professionals with freemium model to land customers and expand through advanced features. Betting on AI-native research workflows to compress traditional research cycles.

Tactics

Open-sourced core scientific skills repository to build developer community and drive platform adoption. Freemium model with $50 free credits removes friction for trial conversion. Heavy focus on scientific validation through Harvard Medical School partnership and real-world case studies like Structure Therapeutics due diligence.

Competitive Positioning

Differentiates from general AI tools by specializing in scientific and biotech analysis with domain-specific multi-agent orchestration. Positions against standalone LLMs by offering hierarchical, multi-agent framework that significantly outperforms on bioinformatics challenges. Premium positioning through exclusive skills and publication-ready outputs.

Marketing Approach

Content-led growth through detailed case studies and technical blog posts demonstrating real-world applications. Academic validation and partnerships with institutions like Harvard Medical School for credibility. Open-source community building to drive awareness and platform adoption among scientific professionals.

Notable

YC-backed, validated by Harvard Medical School Professor David Sinclair, investors include Anthropic and 10x Genomics founders

🔗 Source ↗

Tech Stack

Python 3.9+Claude Opus 4.5Claude Code with Opus 4.5Gemini 3 ProGPUsuv package manager

Recent News

Related AI Agent Companies

Discovery Sources

Signals

trend indicatorSocratic Method🔗 source ↗
trend indicatorLiterature Review🔗 source ↗
trend indicatorAI Research🔗 source ↗
trend indicatorAcademic Writing🔗 source ↗
user countthousands of users

The platform's open-source component is used by "thousands worldwide" and K-Dense Web is trusted by "thousands of professionals"

team size6 employees

The K-Dense team, based in Palo Alto, California, includes **6 named individuals** on its "About Us" page, including Co-Founder & Head of AI, Timothy Kassis, PhD

user count100K+ users (open-source component), thousands of professionals (K-Dense Web)

its open-source component, Claude Scientific Skills, boasts **100k+ users worldwide** [5], and K-Dense Web is used by "thousands of professionals"

funding raised$12M Series A from Accel

Biostate AI secured $12 million in Series A funding led by Accel earlier in 2025

team size6+ employees

The K-Dense team comprises at least **6 individuals** listed on their "About Us" page

user countthousands of professionals

K-Dense Web is used by "thousands of professionals" and K-Dense Beta is being validated with "dozens of design partners"

funding raised$12M Series A led by Accel🔗 source ↗
growth raterapid development and increasing adoption
team size6 core team members
user countthousands of open-source users, dozens of design partners
funding raised$12M Series A
team size7 named individuals
team size7 individuals
user countthousands worldwide
trend indicatorclaude-skills🔗 source ↗
trend indicatorclaudecode🔗 source ↗
trend indicatoragent-skills🔗 source ↗
trend indicatorai-scientist🔗 source ↗
trend indicatorclaude🔗 source ↗
trend indicatorclinical-research🔗 source ↗
trend indicatormaterials-science🔗 source ↗
trend indicatorchemoinformatics🔗 source ↗
trend indicatormetabolomics🔗 source ↗
trend indicatorproteomics🔗 source ↗
trend indicatordata-analysis🔗 source ↗
trend indicatordrug-discovery🔗 source ↗
trend indicatorscientific-computing🔗 source ↗
trend indicatorscientific-visualization🔗 source ↗
trend indicatorcomputational-biology🔗 source ↗
trend indicatorgenomics🔗 source ↗
trend indicatorbioinformatics🔗 source ↗

Evidence

github.com

A comprehensive collection of 170+ ready-to-use scientific and research skills (now including cancer genomics, drug-target binding, molecular dynamics, RNA velocity, geospatial science, time series forecasting, FRED economic data, and more) for any AI agent that supports the open Agent Skills standard, created by K-Dense.

healthtechdigital.com

$12M Series A led by Accel

github.com

Run the pip install academic-research-skills command and try `/ars-plan` to walk through your paper structure via Socratic dialogue.